Market Cap (In TWD)
296.73 Million
Revenue (In TWD)
180.57 Million
Net Income (In TWD)
22.79 Million
Avg. Volume
2013.00
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.0-24.4
- PE
- 18.88
- EPS
- 1.07
- Beta Value
- 0.047
- ISIN
- TW0006744006
- CUSIP
- -
- CIK
- -
- Shares
- 14690000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- -
- Employee Count
- -
- Website
- https://www.fcbiotech.com.tw
- Ipo Date
- 2019-09-25
- Details
- Feng Chi Biotech Corp. provides preimplantation genetic testing, prenatal testing, life science, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services. It also distributes various genetic testing technologies and products in oncology. The company is based in Taipei, Taiwan.
More Stocks
-
GRT
-
VOBIFVobile Group Limited
VOBIF
-
7747GCS
7747
-
SF-PDStifel Financial Corp.
SF-PD
-
PETV
-
NTDTYNTT DATA Corporation
NTDTY
-
LIOPYLion Corporation
LIOPY
-
181710NHN Corporation
181710